Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? (Q44689102)

5 December 2017

title

Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? (English)

1 reference

polycystic ovary syndrome

5 December 2017

main subject

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

cardiovascular disease in women

0 references

1 reference

1 reference

5 December 2017

Loucks TL

1 reference

5 December 2017

McHugh KP

1 reference

5 December 2017

Keelan M

1 reference

5 December 2017

Berga SL

1 reference

5 December 2017

Guzick DS

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

5 December 2017

published in

Fertility and Sterility

1 reference

5 December 2017

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

547-552

1 reference

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Metabolic aspects of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Definition and significance of polycystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Polycystic ovaries--a common finding in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Do hyperandrogenic women with normal menses have polycystic ovary syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Polycystic ovaries in pre and post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Mortality of women with polycystic ovary syndrome at long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2900695-6

10.1016/S0015-0282(00)00695-6

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference